These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 31492821)

  • 1. International Union of Basic and Clinical Pharmacology. CVII. Structure and Pharmacology of the Apelin Receptor with a Recommendation that Elabela/Toddler Is a Second Endogenous Peptide Ligand.
    Read C; Nyimanu D; Williams TL; Huggins DJ; Sulentic P; Macrae RGC; Yang P; Glen RC; Maguire JJ; Davenport AP
    Pharmacol Rev; 2019 Oct; 71(4):467-502. PubMed ID: 31492821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elabela/toddler: New peptide with a promising future in cancer diagnostic and therapy.
    Liet B; Nys N; Siegfried G
    Biochim Biophys Acta Mol Cell Res; 2021 Aug; 1868(9):119065. PubMed ID: 34090960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elabela/Toddler and apelin bind differently to the apelin receptor.
    Couvineau P; Llorens-Cortes C; Iturrioz X
    FASEB J; 2020 Jun; 34(6):7989-8000. PubMed ID: 32301550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apelin and Elabela/Toddler; double ligands for APJ/Apelin receptor in heart development, physiology, and pathology.
    Kuba K; Sato T; Imai Y; Yamaguchi T
    Peptides; 2019 Jan; 111():62-70. PubMed ID: 29684595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apelin, Elabela/Toddler, and biased agonists as novel therapeutic agents in the cardiovascular system.
    Yang P; Maguire JJ; Davenport AP
    Trends Pharmacol Sci; 2015 Sep; 36(9):560-7. PubMed ID: 26143239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting drugs to APJ receptor: From signaling to pathophysiological effects.
    Huang Z; He L; Chen Z; Chen L
    J Cell Physiol; 2018 Jan; 234(1):61-74. PubMed ID: 30070701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elabela/Toddler Is an Endogenous Agonist of the Apelin APJ Receptor in the Adult Cardiovascular System, and Exogenous Administration of the Peptide Compensates for the Downregulation of Its Expression in Pulmonary Arterial Hypertension.
    Yang P; Read C; Kuc RE; Buonincontri G; Southwood M; Torella R; Upton PD; Crosby A; Sawiak SJ; Carpenter TA; Glen RC; Morrell NW; Maguire JJ; Davenport AP
    Circulation; 2017 Mar; 135(12):1160-1173. PubMed ID: 28137936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential Role of the ELABELA-APJ Signaling Pathway in Cardiovascular System Development and Diseases.
    Zhou S; Wang J; Wang Q; Meng Z; Peng J; Song W; Zhou Y; Chen S; Chen F; Sun K
    J Cardiovasc Pharmacol; 2020 Apr; 75(4):284-291. PubMed ID: 32000202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ELABELA-APJ axis protects from pressure overload heart failure and angiotensin II-induced cardiac damage.
    Sato T; Sato C; Kadowaki A; Watanabe H; Ho L; Ishida J; Yamaguchi T; Kimura A; Fukamizu A; Penninger JM; Reversade B; Ito H; Imai Y; Kuba K
    Cardiovasc Res; 2017 Jun; 113(7):760-769. PubMed ID: 28371822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The biological function of ELABELA and APJ signaling in the cardiovascular system and pre-eclampsia.
    Liu Y; Wang L; Shi H
    Hypertens Res; 2019 Jul; 42(7):928-934. PubMed ID: 30626933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-Activity Relationship and Bioactivity of Short Analogues of ELABELA as Agonists of the Apelin Receptor.
    Trân K; Murza A; Sainsily X; Delile E; Couvineau P; Côté J; Coquerel D; Peloquin M; Auger-Messier M; Bouvier M; Lesur O; Sarret P; Marsault É
    J Med Chem; 2021 Jan; 64(1):602-615. PubMed ID: 33350824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of apelin and Elabela in cardiovascular disease.
    Gao S; Chen H
    Biomed Pharmacother; 2023 Oct; 166():115268. PubMed ID: 37562237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological functions of Elabela, a novel endogenous ligand of APJ receptor.
    Xu J; Chen L; Jiang Z; Li L
    J Cell Physiol; 2018 Sep; 233(9):6472-6482. PubMed ID: 29350399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elabela-apelin-12, 17, 36/APJ system promotes platelet aggregation and thrombosis via activating the PANX1-P2X7 signaling pathway.
    Chen Z; Luo X; Liu M; Jiang J; Li Y; Huang Z; Wang L; Cao J; He L; Huang S; Hu H; Li L; Chen L
    J Cell Biochem; 2023 Apr; 124(4):586-605. PubMed ID: 36855998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GPCR structure and function relationship: identification of a biased apelin receptor mutant.
    Ban T; Li X; Ma X; Yang H; Song Y; Sun Y; Shen M; Li N; Zhang MY; Ma Y; Zhong W; Zhang M; Hu LA
    Biochem J; 2018 Dec; 475(23):3813-3826. PubMed ID: 30409826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elabela, a newly discovered APJ ligand: Similarities and differences with Apelin.
    Zhang Y; Wang Y; Lou Y; Luo M; Lu Y; Li Z; Wang Y; Miao L
    Peptides; 2018 Nov; 109():23-32. PubMed ID: 30267732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The functional role of endogenous APJ agonists; Apelin and Elabela/Toddler in cardiovascular diseases].
    Sato T; Kuba K
    Nihon Yakurigaku Zasshi; 2019; 153(4):172-178. PubMed ID: 30971657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ELABELA: a novel hormone in cardiac development acting as a new endogenous ligand for the APJ receptor.
    Xie F; Lv D; Chen L
    Acta Biochim Biophys Sin (Shanghai); 2014 Jul; 46(7):620-2. PubMed ID: 24829400
    [No Abstract]   [Full Text] [Related]  

  • 19. The apelin/APJ system in the regulation of vascular tone: friend or foe?
    Rikitake Y
    J Biochem; 2021 Apr; 169(4):383-386. PubMed ID: 33169143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The apelin receptor: physiology, pathology, cell signalling, and ligand modulation of a peptide-activated class A GPCR.
    Chapman NA; Dupré DJ; Rainey JK
    Biochem Cell Biol; 2014 Dec; 92(6):431-40. PubMed ID: 25275559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.